Cerebral Visual Impairment
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
VAMP2,
PGAP1,
NR2F1,
SPTBN4,
TWNK,
COPB2,
AIMP1,
ST3GAL5,
DPM1,
CRADD,
PRSS12,
KAT6A,
TUSC3,
VPS11,
EZR,
SLC35A2,
FMN2,
MBOAT7,
CCDC47,
CDKL5,
SON,
ST3GAL3,
SCN9A,
SCN1A,
SARS1,
CLIP1,
C12orf4,
PDSS2,
POLG,
MED23
VAMP2,
PGAP1,
NR2F1,
SPTBN4,
TWNK,
COPB2,
AIMP1,
ST3GAL5,
DPM1,
CRADD,
PRSS12,
KAT6A,
TUSC3,
VPS11,
EZR,
SLC35A2,
FMN2,
MBOAT7,
CCDC47,
CDKL5,
SON,
ST3GAL3,
SCN9A,
SCN1A,
SARS1,
CLIP1,
C12orf4,
PDSS2,
POLG,
MED23,
TECR,
CERT1,
FRRS1L,
CRBN,
TRAPPC12,
SLC45A1,
RRM2B,
DCPS,
P4HTM,
CC2D1A,
NSUN2,
COQ2,
PHGDH,
PARS2,
RAB3GAP2,
ADNP,
WARS2,
WASHC4,
POGZ,
EMC1,
TNIK,
RAB18,
RAB3GAP1,
LINS1,
RNF13,
MAN1B1,
POLG2,
KDM5B,
COG5,
RSRC1,
PIGP,
NARS2,
DIAPH1,
DOCK7,
NDST1,
HNMT,
GRIN2D,
GRIK2,
GNB1,
GABRB2,
GABRB1,
TBCK,
PIGS,
METTL23,
ATN1,
TIMM8A,
KIF5A,
TBC1D20,
NADK2,
B3GALNT2,
CLCN4,
FCSK,
CACNA1E,
CACNA1D,
CACNA1B,
ASNS,
ARHGDIA,
SLC25A4,
AMPD2,
FBXO31,
PIGY,
TRAPPC9,
TRNF,
PIGC,
PIGA,
ZC3H14,
NEUROD2,
NAGA,
TRNW,
TRNV,
TRNS2,
TRNS1,
TRNQ,
TRNL1,
TRNK,
ND6,
COX2,
MED25,
LMAN2L,
EDC3,
TRNC,
COX1,
COX3,
CYTB,
ND1,
ND5,
TGFB1,
BLOC1S2,
CD40,
MAPK3,
IL6,
NGLY1,
RTEL1,
ACTB,
UCHL1,
ACP6,
MMP9,
AMD1P2,
CD40LG,
COL1A2,
CSF2,
DAP,
DUSP5,
FCGR2A,
FCGR2B,
IL2,
IL10,
LBR,
MGMT,
CXCL9,
MMP2,
SERPINE1,
IGHV3-75,
PIK3CA,
PIK3CB,
PIK3CD,
PIK3CG,
PON1,
PTPRC,
TIMP1,
TNFRSF1B,
AMD1,
VWF,
FCGR2C,
ZFP30,
AHDC1,
SGSM3,
MIR382
Drugs
—
Registered!
A rare neurologic disease characterized by significant visual dysfunction that cannot be explained by ocular abnormalities alone and is due to damage to post-chiasmatic visual pathways and structures during early perinatal development. Signs and symptoms include decreased visual acuity, visual field defects, and impairments in visual processing and attention.